In a survival analysis of 25 patients with AML NPM1mut, Greiner et al. [45] observed that those exhibiting specific CD8+ cytotoxic T cell immune responses against one or two immunogenic peptides had a better OS compared with those without such immune responses (p = 0.004). Here, CD8A is linked to acute myeloid leukemia.